AARD

3.95

10.43% -0.46

Dopo l'orario di chiusura: 4.92 0.97 +24.56%

Aardvark Therapeutics Inc (AARD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.41

Aprire:

$4.27

Volume 24 ore:

278.72K

Relative Volume:

1.92

Capitalizzazione di mercato:

$86.45M

Reddito:

Utile/perdita netta:

$-69.87M

Rapporto P/E:

-1.231

EPS:

-3.2089

Flusso di cassa netto:

$-61.75M

1 W Prestazione:

+2.33%

1M Prestazione:

-31.30%

6M Prestazione:

-28.57%

1 anno Prestazione:

-63.99%

Intervallo 1D:

$3.89

$4.31

Intervallo di 1 settimana:

$3.64

$4.54

Portata 52W:

$3.35

$16.60

Aardvark Therapeutics Inc Stock (AARD) Company Profile

Nome

Aardvark Therapeutics Inc

Settore

Healthcare (1051)

Industria

Biotechnology (594)

Telefono

(858) 225-7696

Indirizzo

4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-12

Ultimi documenti SEC

AARD's Discussions on Twitter

Compare AARD vs VRTX, REGN, MRNA, ARGX, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AARD Aardvark Therapeutics Inc	3.95	86.45M	0	-69.87M	-61.75M	-3.2089
VRTX Vertex Pharmaceuticals Inc	535.17	135.64B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	819.09	84.33B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	202.63	80.90B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	875.76	55.07B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	382.27	43.24B	5.76B	514.49M	1.10B	4.4813

Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-05-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2026-03-02	Downgrade	H.C. Wainwright	Buy → Neutral
2026-03-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2026-03-02	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2026-03-02	Downgrade	Stifel	Buy → Hold
2026-01-28	Iniziato	B. Riley Securities	Buy
2025-12-23	Iniziato	Oppenheimer	Outperform
2025-12-12	Iniziato	William Blair	Outperform
2025-12-03	Iniziato	Raymond James	Strong Buy
2025-11-07	Iniziato	BTIG Research	Buy
2025-09-29	Iniziato	Stifel	Buy
2025-06-30	Iniziato	H.C. Wainwright	Buy
2025-03-10	Iniziato	BofA Securities	Buy
2025-03-10	Iniziato	Cantor Fitzgerald	Overweight
2025-03-10	Iniziato	Morgan Stanley	Overweight
2025-03-10	Iniziato	RBC Capital Mkts	Outperform

Mostra tutto

Aardvark Therapeutics Inc Borsa (AARD) Ultime notizie

Oct 21, 2026

All You Need to Know About Aardvark Therapeutics, Inc. (AARD) Rating Upgrade to Buy - Zacks Investment Research

Oct 21, 2026

Oct 20, 2026

Attention Long-Term Shareholders of Aardvark Therapeutics, - GlobeNewswire

Oct 20, 2026

Oct 13, 2026

Aardvark Therapeutics, Inc. (NASDAQ: AARD) Investor Alert: Deadline in Lawsuit on October 13, 2026 - openPR.com

Oct 13, 2026

Oct 12, 2026

AARD FINAL DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - PR Newswire

Oct 12, 2026

Oct 11, 2026

AARD DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD - Macau Business

Oct 11, 2026

AARD DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD - GlobeNewswire Inc.

Oct 11, 2026

AARD 截止日期通知：知名律師事務所 ROSEN 提醒 Aardvark Therapeutics, Inc. 投資人，應於證券集體訴訟重要期限 10 月 13 日之前委任法律律師 – AARD - GlobeNewswire Inc.

Oct 11, 2026

AARD DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire

Oct 11, 2026

Oct 10, 2026

URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th - GlobeNewswire Inc.

Oct 10, 2026

URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th - The Daily Tribune News

Oct 10, 2026

URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire

Oct 10, 2026

Lost Money on Aardvark Therapeutics, Inc. (AARD)? Contact Levi & Korsinsky to Join Class Action Before October 13, 2026 - ACCESS Newswire

Oct 10, 2026

Oct 09, 2026

AARD 4-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff DeadlineHBSS - GlobeNewswire Inc.

Oct 09, 2026

Oct 08, 2026

AARD DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD - GlobeNewswire Inc.

Oct 08, 2026

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.

Oct 08, 2026

Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors - GlobeNewswire Inc.

Oct 08, 2026

Oct 07, 2026

AARD Deadline: Rosen Law Firm Urges Aardvark Therapeutics, Inc. (NASDAQ: AARD) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire

Oct 07, 2026

Oct 06, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD - FinancialContent

Oct 06, 2026

Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 06, 2026

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS - GlobeNewswire

Oct 06, 2026

Oct 05, 2026

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors to Secure Counsel Before Important October 13 Deadline - GlobeNewswire Inc.

Oct 05, 2026

Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th - The Daily Tribune News

Oct 05, 2026

Did You Lose Money on Aardvark Therapeutics, Inc. (AARD)? Levi & Korsinsky Urges Investors to Act Before October 13, 2026 - ACCESS Newswire

Oct 05, 2026

Oct 03, 2026

Did You Lose Money on Aardvark Therapeutics, Inc. (AARD)? Levi & Korsinsky Urges Investors to Act Before October 13, 2026 - ACCESS Newswire

Oct 03, 2026

Oct 02, 2026

AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit - the-dispatch.com

Oct 02, 2026